Shefali Agarwal, Director at FATE THERAPEUTICS INC (FATE), sold 841 shares at $21.89 ($18K) on 2022-06-07, disclosed to the SEC on 2022-06-08.
Open-market sale of $18k FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2022-02-04 | $4K | — | Filing → |
| EPZM | SELL | 2022-01-28 | $6K | — | Filing → |
| EPZM | SELL | 2021-12-07 | $5K | — | Filing → |